background image

Sickle Cell Clinical Trials

Find clinical trials for sickle cell. Search for sickle cell clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease

for
Sickle Cell Disease
Location: Los Angeles CA, Oakland CA
Sponsor: Mark Walters, MD

Sex: All

Age: 12 - 35

Code: NCT04774536

Phase1, Phase2, Recruiting
Active & Responsive

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

for
Sickle Cell Disease
Location: Philadelphia PA, Augusta GA, Cleveland OH,
Sponsor: RTI International

Sex: All

Age: 18+

Code: NCT06385886

Recruiting
Active & Responsive

PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD

for
Sickle Cell Disease
Location: Pittsburgh PA
Sponsor: Enrico Novelli

Sex: All

Age: 18+

Code: NCT04925492

Phase1, Recruiting
Active & Responsive

Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0

for
Sickle Cell Disease, Pain, Acupuncture,
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 14 - 70+

Code: NCT06725550

Recruiting
Active & Responsive

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

for
Sickle Cell Disease
Location: Valhalla NY, Gainesville FL, Milwaukee WI,
Sponsor: New York Medical College

Sex: All

Age: 0 - 34

Code: NCT02675959

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease

for
Sickle Cell Disease
Location: Columbus OH, St Louis MO, Los Angeles CA, Palo Alto CA
Sponsor: Kamau Therapeutics

Sex: All

Age: 12 - 40

Code: NCT04819841

Phase1, Phase2, Recruiting
Active & Responsive

Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

for
Sickle Cell Disease
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 16 - 60

Code: NCT03121001

Phase2, Recruiting
Active & Responsive

A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)

for
Sickle Cell Disease
Location: Boston MA, Providence RI, Farmington CT, The Bronx NY,
Sponsor: Agios Pharmaceuticals, Inc.

Sex: All

Age: 16+

Code: NCT06924970

Phase2, Recruiting
Active & Responsive

Effect of Accelerated Neuromodulation of Anterior Cingulate Cortex to Enhance Cognition in Older Adults With Mild Memory Problems

for
Mild Cognitive Impairment (MCI),
Location: Toronto
Sponsor: Rotman Research Institute at Baycrest

Sex: All

Age: 55 - 70+

Code: NCT07212504

Recruiting
New

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

for
Sickle Cell Disease
Location: Columbus OH, Nashville TN, Chicago IL, St Louis MO
Sponsor: Ohio State University

Sex: All

Age: 18+

Code: NCT06919224

Recruiting